nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—ABCB1—colon cancer	0.395	1	CbGaD
Azelastine—CYP2A6—Fluorouracil—colon cancer	0.0815	0.175	CbGbCtD
Azelastine—CYP2B6—Irinotecan—colon cancer	0.0553	0.119	CbGbCtD
Azelastine—CYP2C9—Capecitabine—colon cancer	0.0473	0.102	CbGbCtD
Azelastine—CYP3A5—Irinotecan—colon cancer	0.0436	0.0937	CbGbCtD
Azelastine—CYP2C8—Fluorouracil—colon cancer	0.0402	0.0864	CbGbCtD
Azelastine—CYP3A5—Vincristine—colon cancer	0.0381	0.0819	CbGbCtD
Azelastine—CYP1A2—Fluorouracil—colon cancer	0.0311	0.0669	CbGbCtD
Azelastine—ABCB1—Irinotecan—colon cancer	0.0284	0.061	CbGbCtD
Azelastine—CYP2C9—Fluorouracil—colon cancer	0.028	0.0603	CbGbCtD
Azelastine—ABCB1—Vincristine—colon cancer	0.0248	0.0533	CbGbCtD
Azelastine—CYP3A4—Irinotecan—colon cancer	0.017	0.0365	CbGbCtD
Azelastine—ABCB1—Methotrexate—colon cancer	0.015	0.0323	CbGbCtD
Azelastine—CYP3A4—Vincristine—colon cancer	0.0149	0.0319	CbGbCtD
Azelastine—Mucosal ulceration—Capecitabine—colon cancer	0.0112	0.0924	CcSEcCtD
Azelastine—Nasal discomfort—Fluorouracil—colon cancer	0.00404	0.0333	CcSEcCtD
Azelastine—Dysaesthesia—Fluorouracil—colon cancer	0.00267	0.022	CcSEcCtD
Azelastine—Mucosal inflammation—Irinotecan—colon cancer	0.00218	0.018	CcSEcCtD
Azelastine—Dysaesthesia—Capecitabine—colon cancer	0.00186	0.0154	CcSEcCtD
Azelastine—Mucosal inflammation—Capecitabine—colon cancer	0.00146	0.012	CcSEcCtD
Azelastine—Sneezing—Capecitabine—colon cancer	0.00146	0.012	CcSEcCtD
Azelastine—Stinging—Fluorouracil—colon cancer	0.00142	0.0118	CcSEcCtD
Azelastine—Furunculosis—Methotrexate—colon cancer	0.00141	0.0117	CcSEcCtD
Azelastine—Lacrimation increased—Irinotecan—colon cancer	0.00131	0.0108	CcSEcCtD
Azelastine—Ulcerative stomatitis—Methotrexate—colon cancer	0.0013	0.0107	CcSEcCtD
Azelastine—HRH3—digestive system—colon cancer	0.0013	0.0703	CbGeAlD
Azelastine—Ulcer—Irinotecan—colon cancer	0.00127	0.0105	CcSEcCtD
Azelastine—Lacrimation increased—Fluorouracil—colon cancer	0.00125	0.0103	CcSEcCtD
Azelastine—Herpes simplex—Fluorouracil—colon cancer	0.00125	0.0103	CcSEcCtD
Azelastine—Furuncle—Methotrexate—colon cancer	0.00122	0.0101	CcSEcCtD
Azelastine—Ulcer—Fluorouracil—colon cancer	0.00122	0.0101	CcSEcCtD
Azelastine—Pharyngolaryngeal pain—Capecitabine—colon cancer	0.00119	0.00986	CcSEcCtD
Azelastine—Laryngeal pain—Capecitabine—colon cancer	0.00118	0.00977	CcSEcCtD
Azelastine—Dermatitis contact—Fluorouracil—colon cancer	0.00114	0.00941	CcSEcCtD
Azelastine—Laryngitis—Capecitabine—colon cancer	0.00112	0.00924	CcSEcCtD
Azelastine—Mouth ulceration—Vincristine—colon cancer	0.00112	0.00923	CcSEcCtD
Azelastine—Mucosal inflammation—Methotrexate—colon cancer	0.00108	0.00895	CcSEcCtD
Azelastine—Ageusia—Capecitabine—colon cancer	0.000995	0.00822	CcSEcCtD
Azelastine—Anaphylactoid reaction—Irinotecan—colon cancer	0.000904	0.00746	CcSEcCtD
Azelastine—Lacrimation increased—Capecitabine—colon cancer	0.000875	0.00722	CcSEcCtD
Azelastine—Herpes simplex—Capecitabine—colon cancer	0.000875	0.00722	CcSEcCtD
Azelastine—Urinary retention—Vincristine—colon cancer	0.000854	0.00705	CcSEcCtD
Azelastine—Ulcer—Capecitabine—colon cancer	0.000853	0.00704	CcSEcCtD
Azelastine—ADRA1B—renal system—colon cancer	0.000844	0.0456	CbGeAlD
Azelastine—Influenza like illness—Capecitabine—colon cancer	0.000783	0.00646	CcSEcCtD
Azelastine—Nasopharyngitis—Fluorouracil—colon cancer	0.000749	0.00618	CcSEcCtD
Azelastine—Mouth ulceration—Capecitabine—colon cancer	0.000729	0.00602	CcSEcCtD
Azelastine—Abnormal vision—Capecitabine—colon cancer	0.000703	0.00581	CcSEcCtD
Azelastine—Upper respiratory tract infection—Irinotecan—colon cancer	0.000703	0.0058	CcSEcCtD
Azelastine—Mental disability—Capecitabine—colon cancer	0.0007	0.00578	CcSEcCtD
Azelastine—Sleep disorder—Capecitabine—colon cancer	0.000676	0.00558	CcSEcCtD
Azelastine—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000673	0.00555	CcSEcCtD
Azelastine—Gastroenteritis—Capecitabine—colon cancer	0.000661	0.00545	CcSEcCtD
Azelastine—Glossitis—Methotrexate—colon cancer	0.000651	0.00538	CcSEcCtD
Azelastine—Herpes simplex—Methotrexate—colon cancer	0.000651	0.00538	CcSEcCtD
Azelastine—Eye pain—Capecitabine—colon cancer	0.000648	0.00535	CcSEcCtD
Azelastine—Ulcer—Methotrexate—colon cancer	0.000635	0.00524	CcSEcCtD
Azelastine—Conjunctivitis—Fluorouracil—colon cancer	0.000628	0.00518	CcSEcCtD
Azelastine—Increased appetite—Capecitabine—colon cancer	0.000623	0.00514	CcSEcCtD
Azelastine—Hypoaesthesia—Vincristine—colon cancer	0.000618	0.0051	CcSEcCtD
Azelastine—Atrial fibrillation—Capecitabine—colon cancer	0.000618	0.0051	CcSEcCtD
Azelastine—Epistaxis—Fluorouracil—colon cancer	0.000609	0.00503	CcSEcCtD
Azelastine—Rhinitis—Irinotecan—colon cancer	0.000607	0.00501	CcSEcCtD
Azelastine—Sinusitis—Fluorouracil—colon cancer	0.000606	0.005	CcSEcCtD
Azelastine—Arthritis—Capecitabine—colon cancer	0.000602	0.00497	CcSEcCtD
Azelastine—Visual impairment—Irinotecan—colon cancer	0.000583	0.00481	CcSEcCtD
Azelastine—Rhinitis—Fluorouracil—colon cancer	0.000581	0.0048	CcSEcCtD
Azelastine—Hypoaesthesia—Fluorouracil—colon cancer	0.000577	0.00476	CcSEcCtD
Azelastine—Pharyngitis—Fluorouracil—colon cancer	0.000575	0.00475	CcSEcCtD
Azelastine—Face oedema—Capecitabine—colon cancer	0.000565	0.00467	CcSEcCtD
Azelastine—Flushing—Irinotecan—colon cancer	0.000562	0.00464	CcSEcCtD
Azelastine—Urinary retention—Capecitabine—colon cancer	0.000557	0.00459	CcSEcCtD
Azelastine—Mouth ulceration—Methotrexate—colon cancer	0.000543	0.00448	CcSEcCtD
Azelastine—CYP2A6—vagina—colon cancer	0.000541	0.0292	CbGeAlD
Azelastine—Nasopharyngitis—Capecitabine—colon cancer	0.000524	0.00432	CcSEcCtD
Azelastine—Back pain—Vincristine—colon cancer	0.000523	0.00432	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000516	0.00426	CcSEcCtD
Azelastine—Back pain—Irinotecan—colon cancer	0.00051	0.00421	CcSEcCtD
Azelastine—Asthma—Capecitabine—colon cancer	0.000506	0.00418	CcSEcCtD
Azelastine—Bronchospasm—Capecitabine—colon cancer	0.000498	0.00411	CcSEcCtD
Azelastine—Agitation—Vincristine—colon cancer	0.000497	0.0041	CcSEcCtD
Azelastine—Ill-defined disorder—Irinotecan—colon cancer	0.000489	0.00403	CcSEcCtD
Azelastine—Bronchitis—Capecitabine—colon cancer	0.000487	0.00402	CcSEcCtD
Azelastine—Vertigo—Vincristine—colon cancer	0.000486	0.00401	CcSEcCtD
Azelastine—Vision blurred—Fluorouracil—colon cancer	0.000475	0.00392	CcSEcCtD
Azelastine—Malaise—Irinotecan—colon cancer	0.000475	0.00392	CcSEcCtD
Azelastine—Vertigo—Irinotecan—colon cancer	0.000473	0.00391	CcSEcCtD
Azelastine—Upper respiratory tract infection—Capecitabine—colon cancer	0.00047	0.00388	CcSEcCtD
Azelastine—Hypertension—Vincristine—colon cancer	0.000467	0.00385	CcSEcCtD
Azelastine—Myalgia—Vincristine—colon cancer	0.000461	0.0038	CcSEcCtD
Azelastine—Weight increased—Capecitabine—colon cancer	0.00046	0.0038	CcSEcCtD
Azelastine—Cough—Irinotecan—colon cancer	0.00046	0.00379	CcSEcCtD
Azelastine—KCNH2—renal system—colon cancer	0.000458	0.0247	CbGeAlD
Azelastine—CYP2A6—liver—colon cancer	0.000456	0.0246	CbGeAlD
Azelastine—Hypertension—Irinotecan—colon cancer	0.000455	0.00375	CcSEcCtD
Azelastine—Anaphylactoid reaction—Methotrexate—colon cancer	0.00045	0.00372	CcSEcCtD
Azelastine—ABCB1—blood vessel—colon cancer	0.000445	0.024	CbGeAlD
Azelastine—Discomfort—Irinotecan—colon cancer	0.000443	0.00366	CcSEcCtD
Azelastine—Anaphylactic shock—Vincristine—colon cancer	0.000441	0.00364	CcSEcCtD
Azelastine—Infection—Vincristine—colon cancer	0.000439	0.00362	CcSEcCtD
Azelastine—Conjunctivitis—Capecitabine—colon cancer	0.000439	0.00362	CcSEcCtD
Azelastine—Confusional state—Irinotecan—colon cancer	0.000433	0.00358	CcSEcCtD
Azelastine—Haematuria—Capecitabine—colon cancer	0.00043	0.00355	CcSEcCtD
Azelastine—Anaphylactic shock—Irinotecan—colon cancer	0.00043	0.00355	CcSEcCtD
Azelastine—Myalgia—Fluorouracil—colon cancer	0.00043	0.00355	CcSEcCtD
Azelastine—Chest pain—Fluorouracil—colon cancer	0.00043	0.00355	CcSEcCtD
Azelastine—Infection—Irinotecan—colon cancer	0.000427	0.00353	CcSEcCtD
Azelastine—Epistaxis—Capecitabine—colon cancer	0.000426	0.00351	CcSEcCtD
Azelastine—Discomfort—Fluorouracil—colon cancer	0.000424	0.0035	CcSEcCtD
Azelastine—CYP2C8—renal system—colon cancer	0.000419	0.0226	CbGeAlD
Azelastine—CYP1A1—epithelium—colon cancer	0.000417	0.0225	CbGeAlD
Azelastine—Confusional state—Fluorouracil—colon cancer	0.000415	0.00343	CcSEcCtD
Azelastine—Anaphylactic shock—Fluorouracil—colon cancer	0.000412	0.0034	CcSEcCtD
Azelastine—Infection—Fluorouracil—colon cancer	0.000409	0.00338	CcSEcCtD
Azelastine—Rhinitis—Capecitabine—colon cancer	0.000406	0.00335	CcSEcCtD
Azelastine—Hypoaesthesia—Capecitabine—colon cancer	0.000403	0.00333	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000402	0.00332	CcSEcCtD
Azelastine—Pharyngitis—Capecitabine—colon cancer	0.000402	0.00332	CcSEcCtD
Azelastine—Tachycardia—Fluorouracil—colon cancer	0.000402	0.00332	CcSEcCtD
Azelastine—Paraesthesia—Vincristine—colon cancer	0.000396	0.00327	CcSEcCtD
Azelastine—HRH1—epithelium—colon cancer	0.000396	0.0214	CbGeAlD
Azelastine—CYP2C19—digestive system—colon cancer	0.000394	0.0213	CbGeAlD
Azelastine—CYP1A2—renal system—colon cancer	0.000392	0.0212	CbGeAlD
Azelastine—Visual impairment—Capecitabine—colon cancer	0.00039	0.00322	CcSEcCtD
Azelastine—CYP1A1—renal system—colon cancer	0.000387	0.0209	CbGeAlD
Azelastine—Paraesthesia—Irinotecan—colon cancer	0.000386	0.00319	CcSEcCtD
Azelastine—Dyspnoea—Irinotecan—colon cancer	0.000383	0.00316	CcSEcCtD
Azelastine—Somnolence—Irinotecan—colon cancer	0.000382	0.00315	CcSEcCtD
Azelastine—HRH1—smooth muscle tissue—colon cancer	0.000381	0.0206	CbGeAlD
Azelastine—Fatigue—Vincristine—colon cancer	0.000381	0.00314	CcSEcCtD
Azelastine—Eye disorder—Capecitabine—colon cancer	0.000378	0.00312	CcSEcCtD
Azelastine—CYP3A5—renal system—colon cancer	0.000378	0.0204	CbGeAlD
Azelastine—Constipation—Vincristine—colon cancer	0.000378	0.00312	CcSEcCtD
Azelastine—Pain—Vincristine—colon cancer	0.000378	0.00312	CcSEcCtD
Azelastine—Asthma—Methotrexate—colon cancer	0.000377	0.00311	CcSEcCtD
Azelastine—Flushing—Capecitabine—colon cancer	0.000376	0.0031	CcSEcCtD
Azelastine—CYP2B6—renal system—colon cancer	0.000376	0.0203	CbGeAlD
Azelastine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000375	0.0031	CcSEcCtD
Azelastine—Fatigue—Irinotecan—colon cancer	0.000371	0.00306	CcSEcCtD
Azelastine—Paraesthesia—Fluorouracil—colon cancer	0.00037	0.00305	CcSEcCtD
Azelastine—Constipation—Irinotecan—colon cancer	0.000368	0.00303	CcSEcCtD
Azelastine—Pain—Irinotecan—colon cancer	0.000368	0.00303	CcSEcCtD
Azelastine—Dyspnoea—Fluorouracil—colon cancer	0.000367	0.00303	CcSEcCtD
Azelastine—Somnolence—Fluorouracil—colon cancer	0.000366	0.00302	CcSEcCtD
Azelastine—Gastrointestinal pain—Vincristine—colon cancer	0.000361	0.00298	CcSEcCtD
Azelastine—Feeling abnormal—Irinotecan—colon cancer	0.000354	0.00292	CcSEcCtD
Azelastine—CYP2E1—renal system—colon cancer	0.000353	0.0191	CbGeAlD
Azelastine—Pain—Fluorouracil—colon cancer	0.000352	0.00291	CcSEcCtD
Azelastine—Gastrointestinal pain—Irinotecan—colon cancer	0.000352	0.0029	CcSEcCtD
Azelastine—Upper respiratory tract infection—Methotrexate—colon cancer	0.00035	0.00289	CcSEcCtD
Azelastine—Body temperature increased—Vincristine—colon cancer	0.000349	0.00288	CcSEcCtD
Azelastine—Abdominal pain—Vincristine—colon cancer	0.000349	0.00288	CcSEcCtD
Azelastine—CYP2C19—vagina—colon cancer	0.000348	0.0188	CbGeAlD
Azelastine—KCNH2—bone marrow—colon cancer	0.000346	0.0187	CbGeAlD
Azelastine—Dysgeusia—Capecitabine—colon cancer	0.000345	0.00285	CcSEcCtD
Azelastine—Back pain—Capecitabine—colon cancer	0.000341	0.00281	CcSEcCtD
Azelastine—Body temperature increased—Irinotecan—colon cancer	0.00034	0.00281	CcSEcCtD
Azelastine—Abdominal pain—Irinotecan—colon cancer	0.00034	0.00281	CcSEcCtD
Azelastine—Feeling abnormal—Fluorouracil—colon cancer	0.000339	0.0028	CcSEcCtD
Azelastine—Vision blurred—Capecitabine—colon cancer	0.000332	0.00274	CcSEcCtD
Azelastine—KCNH2—vagina—colon cancer	0.000332	0.0179	CbGeAlD
Azelastine—Ill-defined disorder—Capecitabine—colon cancer	0.000327	0.0027	CcSEcCtD
Azelastine—Conjunctivitis—Methotrexate—colon cancer	0.000326	0.00269	CcSEcCtD
Azelastine—Body temperature increased—Fluorouracil—colon cancer	0.000326	0.00269	CcSEcCtD
Azelastine—Hypersensitivity—Vincristine—colon cancer	0.000325	0.00268	CcSEcCtD
Azelastine—CYP1A2—digestive system—colon cancer	0.000322	0.0174	CbGeAlD
Azelastine—Haematuria—Methotrexate—colon cancer	0.00032	0.00264	CcSEcCtD
Azelastine—Malaise—Capecitabine—colon cancer	0.000318	0.00262	CcSEcCtD
Azelastine—CYP1A1—digestive system—colon cancer	0.000317	0.0171	CbGeAlD
Azelastine—Epistaxis—Methotrexate—colon cancer	0.000317	0.00261	CcSEcCtD
Azelastine—Vertigo—Capecitabine—colon cancer	0.000317	0.00261	CcSEcCtD
Azelastine—Hypersensitivity—Irinotecan—colon cancer	0.000317	0.00261	CcSEcCtD
Azelastine—Asthenia—Vincristine—colon cancer	0.000317	0.00261	CcSEcCtD
Azelastine—CYP2B6—lymphoid tissue—colon cancer	0.000312	0.0169	CbGeAlD
Azelastine—Palpitations—Capecitabine—colon cancer	0.000312	0.00257	CcSEcCtD
Azelastine—CYP3A5—digestive system—colon cancer	0.00031	0.0168	CbGeAlD
Azelastine—Asthenia—Irinotecan—colon cancer	0.000308	0.00255	CcSEcCtD
Azelastine—CYP2B6—digestive system—colon cancer	0.000308	0.0167	CbGeAlD
Azelastine—Cough—Capecitabine—colon cancer	0.000308	0.00254	CcSEcCtD
Azelastine—CYP2C9—digestive system—colon cancer	0.000305	0.0165	CbGeAlD
Azelastine—Hypertension—Capecitabine—colon cancer	0.000304	0.00251	CcSEcCtD
Azelastine—CYP2C8—vagina—colon cancer	0.000303	0.0164	CbGeAlD
Azelastine—Hypersensitivity—Fluorouracil—colon cancer	0.000303	0.0025	CcSEcCtD
Azelastine—Diarrhoea—Vincristine—colon cancer	0.000302	0.00249	CcSEcCtD
Azelastine—HRH1—digestive system—colon cancer	0.000301	0.0163	CbGeAlD
Azelastine—Myalgia—Capecitabine—colon cancer	0.0003	0.00248	CcSEcCtD
Azelastine—Chest pain—Capecitabine—colon cancer	0.0003	0.00248	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—colon cancer	0.000299	0.00247	CcSEcCtD
Azelastine—Anxiety—Capecitabine—colon cancer	0.000299	0.00247	CcSEcCtD
Azelastine—Discomfort—Capecitabine—colon cancer	0.000297	0.00245	CcSEcCtD
Azelastine—Diarrhoea—Irinotecan—colon cancer	0.000294	0.00243	CcSEcCtD
Azelastine—Dry mouth—Capecitabine—colon cancer	0.000294	0.00242	CcSEcCtD
Azelastine—CYP2C19—liver—colon cancer	0.000293	0.0159	CbGeAlD
Azelastine—CYP2E1—lymphoid tissue—colon cancer	0.000293	0.0158	CbGeAlD
Azelastine—Dizziness—Vincristine—colon cancer	0.000292	0.00241	CcSEcCtD
Azelastine—Pruritus—Fluorouracil—colon cancer	0.000291	0.0024	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—colon cancer	0.000291	0.0024	CcSEcCtD
Azelastine—Confusional state—Capecitabine—colon cancer	0.00029	0.00239	CcSEcCtD
Azelastine—CYP2E1—digestive system—colon cancer	0.000289	0.0156	CbGeAlD
Azelastine—Infection—Capecitabine—colon cancer	0.000286	0.00236	CcSEcCtD
Azelastine—Dizziness—Irinotecan—colon cancer	0.000284	0.00235	CcSEcCtD
Azelastine—CYP3A4—renal system—colon cancer	0.000284	0.0153	CbGeAlD
Azelastine—Eye disorder—Methotrexate—colon cancer	0.000282	0.00233	CcSEcCtD
Azelastine—Diarrhoea—Fluorouracil—colon cancer	0.000282	0.00233	CcSEcCtD
Azelastine—Tachycardia—Capecitabine—colon cancer	0.000281	0.00232	CcSEcCtD
Azelastine—Vomiting—Vincristine—colon cancer	0.000281	0.00232	CcSEcCtD
Azelastine—CYP1A1—vagina—colon cancer	0.00028	0.0151	CbGeAlD
Azelastine—CYP2D6—renal system—colon cancer	0.000279	0.0151	CbGeAlD
Azelastine—Rash—Vincristine—colon cancer	0.000278	0.0023	CcSEcCtD
Azelastine—Dermatitis—Vincristine—colon cancer	0.000278	0.0023	CcSEcCtD
Azelastine—Headache—Vincristine—colon cancer	0.000277	0.00228	CcSEcCtD
Azelastine—CYP3A5—vagina—colon cancer	0.000274	0.0148	CbGeAlD
Azelastine—Vomiting—Irinotecan—colon cancer	0.000273	0.00226	CcSEcCtD
Azelastine—Dizziness—Fluorouracil—colon cancer	0.000272	0.00225	CcSEcCtD
Azelastine—CYP2B6—vagina—colon cancer	0.000272	0.0147	CbGeAlD
Azelastine—Rash—Irinotecan—colon cancer	0.000271	0.00224	CcSEcCtD
Azelastine—Dermatitis—Irinotecan—colon cancer	0.000271	0.00224	CcSEcCtD
Azelastine—Headache—Irinotecan—colon cancer	0.000269	0.00222	CcSEcCtD
Azelastine—HRH1—vagina—colon cancer	0.000266	0.0144	CbGeAlD
Azelastine—ABCB1—embryo—colon cancer	0.000265	0.0143	CbGeAlD
Azelastine—Nausea—Vincristine—colon cancer	0.000262	0.00216	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000262	0.00216	CcSEcCtD
Azelastine—Vomiting—Fluorouracil—colon cancer	0.000262	0.00216	CcSEcCtD
Azelastine—Rash—Fluorouracil—colon cancer	0.00026	0.00214	CcSEcCtD
Azelastine—Dermatitis—Fluorouracil—colon cancer	0.000259	0.00214	CcSEcCtD
Azelastine—Paraesthesia—Capecitabine—colon cancer	0.000258	0.00213	CcSEcCtD
Azelastine—Headache—Fluorouracil—colon cancer	0.000258	0.00213	CcSEcCtD
Azelastine—Dysgeusia—Methotrexate—colon cancer	0.000257	0.00212	CcSEcCtD
Azelastine—Dyspnoea—Capecitabine—colon cancer	0.000257	0.00212	CcSEcCtD
Azelastine—CYP2C8—liver—colon cancer	0.000256	0.0138	CbGeAlD
Azelastine—Nausea—Irinotecan—colon cancer	0.000255	0.00211	CcSEcCtD
Azelastine—Back pain—Methotrexate—colon cancer	0.000254	0.0021	CcSEcCtD
Azelastine—Fatigue—Capecitabine—colon cancer	0.000248	0.00205	CcSEcCtD
Azelastine—Vision blurred—Methotrexate—colon cancer	0.000247	0.00204	CcSEcCtD
Azelastine—Pain—Capecitabine—colon cancer	0.000246	0.00203	CcSEcCtD
Azelastine—Constipation—Capecitabine—colon cancer	0.000246	0.00203	CcSEcCtD
Azelastine—Nausea—Fluorouracil—colon cancer	0.000245	0.00202	CcSEcCtD
Azelastine—Ill-defined disorder—Methotrexate—colon cancer	0.000244	0.00201	CcSEcCtD
Azelastine—CYP1A2—liver—colon cancer	0.00024	0.0129	CbGeAlD
Azelastine—Feeling abnormal—Capecitabine—colon cancer	0.000237	0.00196	CcSEcCtD
Azelastine—Malaise—Methotrexate—colon cancer	0.000237	0.00195	CcSEcCtD
Azelastine—CYP1A1—liver—colon cancer	0.000236	0.0128	CbGeAlD
Azelastine—Vertigo—Methotrexate—colon cancer	0.000236	0.00195	CcSEcCtD
Azelastine—Gastrointestinal pain—Capecitabine—colon cancer	0.000235	0.00194	CcSEcCtD
Azelastine—CYP3A4—digestive system—colon cancer	0.000233	0.0126	CbGeAlD
Azelastine—CYP3A5—liver—colon cancer	0.000231	0.0125	CbGeAlD
Azelastine—CYP2B6—liver—colon cancer	0.00023	0.0124	CbGeAlD
Azelastine—CYP2D6—digestive system—colon cancer	0.000229	0.0124	CbGeAlD
Azelastine—Cough—Methotrexate—colon cancer	0.000229	0.00189	CcSEcCtD
Azelastine—Abdominal pain—Capecitabine—colon cancer	0.000227	0.00188	CcSEcCtD
Azelastine—Body temperature increased—Capecitabine—colon cancer	0.000227	0.00188	CcSEcCtD
Azelastine—CYP2C9—liver—colon cancer	0.000227	0.0123	CbGeAlD
Azelastine—Myalgia—Methotrexate—colon cancer	0.000223	0.00184	CcSEcCtD
Azelastine—Chest pain—Methotrexate—colon cancer	0.000223	0.00184	CcSEcCtD
Azelastine—Discomfort—Methotrexate—colon cancer	0.000221	0.00182	CcSEcCtD
Azelastine—ABCB1—epithelium—colon cancer	0.000217	0.0117	CbGeAlD
Azelastine—Confusional state—Methotrexate—colon cancer	0.000216	0.00178	CcSEcCtD
Azelastine—CYP2E1—liver—colon cancer	0.000216	0.0116	CbGeAlD
Azelastine—KCNH2—lymph node—colon cancer	0.000215	0.0116	CbGeAlD
Azelastine—Anaphylactic shock—Methotrexate—colon cancer	0.000214	0.00177	CcSEcCtD
Azelastine—Infection—Methotrexate—colon cancer	0.000213	0.00176	CcSEcCtD
Azelastine—Hypersensitivity—Capecitabine—colon cancer	0.000212	0.00175	CcSEcCtD
Azelastine—Asthenia—Capecitabine—colon cancer	0.000206	0.0017	CcSEcCtD
Azelastine—Pruritus—Capecitabine—colon cancer	0.000204	0.00168	CcSEcCtD
Azelastine—ABCB1—renal system—colon cancer	0.000201	0.0109	CbGeAlD
Azelastine—Diarrhoea—Capecitabine—colon cancer	0.000197	0.00163	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000195	0.00161	CcSEcCtD
Azelastine—Paraesthesia—Methotrexate—colon cancer	0.000192	0.00159	CcSEcCtD
Azelastine—Dyspnoea—Methotrexate—colon cancer	0.000191	0.00158	CcSEcCtD
Azelastine—Somnolence—Methotrexate—colon cancer	0.00019	0.00157	CcSEcCtD
Azelastine—Dizziness—Capecitabine—colon cancer	0.00019	0.00157	CcSEcCtD
Azelastine—Fatigue—Methotrexate—colon cancer	0.000185	0.00152	CcSEcCtD
Azelastine—Pain—Methotrexate—colon cancer	0.000183	0.00151	CcSEcCtD
Azelastine—Vomiting—Capecitabine—colon cancer	0.000183	0.00151	CcSEcCtD
Azelastine—Rash—Capecitabine—colon cancer	0.000181	0.0015	CcSEcCtD
Azelastine—Dermatitis—Capecitabine—colon cancer	0.000181	0.0015	CcSEcCtD
Azelastine—CYP1A1—lymph node—colon cancer	0.000181	0.00979	CbGeAlD
Azelastine—Headache—Capecitabine—colon cancer	0.00018	0.00149	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—colon cancer	0.000177	0.00146	CcSEcCtD
Azelastine—Gastrointestinal pain—Methotrexate—colon cancer	0.000175	0.00145	CcSEcCtD
Azelastine—CYP3A4—liver—colon cancer	0.000173	0.00937	CbGeAlD
Azelastine—HRH1—lymph node—colon cancer	0.000172	0.00929	CbGeAlD
Azelastine—Nausea—Capecitabine—colon cancer	0.000171	0.00141	CcSEcCtD
Azelastine—CYP2D6—liver—colon cancer	0.000171	0.00922	CbGeAlD
Azelastine—Body temperature increased—Methotrexate—colon cancer	0.000169	0.0014	CcSEcCtD
Azelastine—Abdominal pain—Methotrexate—colon cancer	0.000169	0.0014	CcSEcCtD
Azelastine—ABCB1—lymphoid tissue—colon cancer	0.000167	0.00901	CbGeAlD
Azelastine—ABCB1—digestive system—colon cancer	0.000165	0.0089	CbGeAlD
Azelastine—Hypersensitivity—Methotrexate—colon cancer	0.000158	0.0013	CcSEcCtD
Azelastine—Asthenia—Methotrexate—colon cancer	0.000154	0.00127	CcSEcCtD
Azelastine—ABCB1—bone marrow—colon cancer	0.000152	0.00821	CbGeAlD
Azelastine—Pruritus—Methotrexate—colon cancer	0.000152	0.00125	CcSEcCtD
Azelastine—Diarrhoea—Methotrexate—colon cancer	0.000147	0.00121	CcSEcCtD
Azelastine—ABCB1—vagina—colon cancer	0.000146	0.00786	CbGeAlD
Azelastine—Dizziness—Methotrexate—colon cancer	0.000142	0.00117	CcSEcCtD
Azelastine—Vomiting—Methotrexate—colon cancer	0.000136	0.00112	CcSEcCtD
Azelastine—Rash—Methotrexate—colon cancer	0.000135	0.00111	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—colon cancer	0.000135	0.00111	CcSEcCtD
Azelastine—Headache—Methotrexate—colon cancer	0.000134	0.00111	CcSEcCtD
Azelastine—Nausea—Methotrexate—colon cancer	0.000127	0.00105	CcSEcCtD
Azelastine—ABCB1—liver—colon cancer	0.000123	0.00663	CbGeAlD
Azelastine—ABCB1—lymph node—colon cancer	9.41e-05	0.00509	CbGeAlD
